Skip to main content

Pairings: Mar 30, 2011

Premium

PrognosDx Health announced that A. Franklin Rice has joined its board of directors. Rice is a member of BayBio Northern California's Life Science Association and "brings a wealth of experience in finance and administration to PrognosDx's board of directors," the company said in a statement.

Rice is currently the chief financial officer of the stem cell-based drug company VistaGen Therapeutics. He has held various positions in the biotech industry for 20 years.


According to documents filed with the US Securities and Exchange Commission, Genomic Health announced that Brook Byers will retire from its board of directors as of June 9. Byers has been a member of Genomic Health's board since 2001.

Byers is a senior partner at Kleiner Perkins Caufield & Byers. Since becoming a venture capital investor in 1972, he as been intimately involved with launching more than fifty technology companies.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.